(Q24197803)

2

0 references

Zhijian Zhang

3

0 references

Zuhui Chen

4

0 references

Bin Zhao

Cochrane Database of Systematic Reviews

5

0 references

publication date

30 April 2013

0 references

published in

0 references

cites work

A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Effects of sinvastatin in prevention of vasospasm in nontraumatic subarachnoid hemorrhage: preliminary data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Effects of simvastatin in prevention of vasospasm in nontraumatic subarachnoid hemorrhage: preliminary data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Biological effects of acute pravastatin treatment in patients after aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Effects of acute treatment with statins on cerebral autoregulation in patients after aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Atorvastatin ameliorates cerebral vasospasm and early brain injury after subarachnoid hemorrhage and inhibits caspase-dependent apoptosis pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Modulation of COX-2 expression by statins in human aortic smooth muscle cells. Involvement of geranylgeranylated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Calcium antagonists for aneurysmal subarachnoid haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Cerebral vasospasm after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Statins may not protect against vasospasm in subarachnoid haemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

A case control study of statin and magnesium administration in patients after aneurysmal subarachnoid hemorrhage: incidence of delayed cerebral ischemia and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Lovastatin enhances ecto-5'-nucleotidase activity and cell surface expression in endothelial cells: implication of rho-family GTPases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Nitric oxide insufficiency, platelet activation, and arterial thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Cerebral vasospasm and free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Statins: effects beyond cholesterol lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Simvastatin re-couples dysfunctional endothelial nitric oxide synthase in experimental subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Atorvastatin decreases computed tomography and S100-assessed brain ischemia after subarachnoid aneurysmal hemorrhage: a comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Simvastatin attenuation of cerebral vasospasm after subarachnoid hemorrhage in rats via increased phosphorylation of Akt and endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Statin treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Evidence-based cerebral vasospasm management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

7 January 2021

Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

7 January 2021

Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

7 January 2021

Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a single-institution prospective cohort study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008184.PUB2

7 January 2021